Global Autotransfusion Devices Market 2020-2024 | Evolving Opportunities with Haemonetics Corp. and LivaNova Plc | Technavio
LONDON--(BUSINESS WIRE)--Nov 12, 2019--
The global autotransfusion devices market size is poised to grow by USD 76.23 million during 2020-2024, registering a CAGR of close to 6% during the forecast period. Request Free Sample Pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112005795/en/
Technavio has announced its latest market research report titled global autotransfusion devices market 2020-2024. (Graphic: Business Wire)
Read the 151-page research report with TOC on “Autotransfusion Devices Market Analysis Report by product (systems and accessories), by geography (North America, Europe, Asia, and ROW), and Segment Forecasts, 2020-2024”.
The market is driven by the rising number of cardiac and orthopedic surgeries. In addition, continuous technological advances are anticipated to further boost the growth of the autotransfusion devices market.
Blood transfusion is one of the key procedures to be performed during the intraoperative or postoperative procedures. Allogenic blood transfusion is mainly performed during the procedures, which may lead to various bacterial and viral infections. As a result, to avoid the risk of infection, autologous transfusions are being performed during these surgical procedures. Thus, an increase in various surgical procedures across the globe is expected to drive the global autotransfusion devices market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for FREE.
Major Five Autotransfusion Devices Market Companies:
Headquartered in the US, Haemonetics Corp. offers products through segments, namely plasma, blood center, and hospital. The company offers Cell Saver 5+, Cell Saver Elite+, and Cell Saver Elite as the key product offerings for the autotransfusion devices market. In May 2019, the company received clearance for the expanded use of TEG 6s Hemostasis Analyzer System in adult trauma settings.
LivaNova Plc operates its business under two segments such as cardiovascular and neuromodulation. In July 2019, the company launched Bi-Flow, an innovative arterial femoral cannula to prevent limb ischemia during cardiac surgery. The company offers XTRA as its key offering which features innovative technological characteristics to help clinicians perform autotransfusion effectively.
Medtronic Plc has business operations under various segments, which include cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. The company offers the autoLog autotransfusion system with an effective design to provide autologous blood during surgical procedures. In October 2019, the company launched GI Genius intelligent endoscopy module in Spain.
Getinge AB operates through various business segments including acute care therapies, surgical workflows, and lifesciences. The company offers 2450 self-filling autotransfusion blood bags and 2550 in-line autotransfusion blood bags as its key offerings.
Teleflex Inc. offers products through various business segments including surgical North America, vascular North America, interventional North America, anesthesia North America, EMEA, Asia, OEM, and all others. The company offers the Pleur-evac autotransfusion capability, an autotransfusion blood bag used during chest drainage. In May 2018, the company launched TrapLine catheter in Europe and showcased Arrow AC3 Optimus Intra-Aortic Balloon Pump (IABP).
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Autotransfusion Devices Product Outlook (Revenue, USD Million, 2020-2024)
Autotransfusion Devices Regional Outlook (Revenue, USD Million, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191112005795/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 11/12/2019 05:00 PM/DISC: 11/12/2019 05:00 PM